Dithranol: A review of the mechanism of action in the treatment of psoriasis vulgaris

L. Kemény, Thomas Ruzicka, Otto Braun-Falco

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Dithranol is highly effective in the treatment of psoriasis. The drug inhibits keratinocyte hyperproliferation, granulocyte function and, in addition, may exert an immunosuppressive effect. Free radicals, histamine, eicosanoids and platelet-activating factor have been shown to be involved in dithranol-induced dermatitis, and the oxidation products of the drug are responsible for the staining. Our experimental data suggest that extracellularly generated oxygen free radicals are responsible for both the antipsoriatic and irritative effect of the drug. Furthermore, we could recently provide evidence that extracellularly generated superoxide anion radical also induces an active adaptation mechanism resulting in increased tolerance to dithranol upon repeated application. This adaptive process may explain the requirement for increasing dithranol concentrations to maintain the antipsoriatic efficacy, and also the beneficial effect of other antipsoriatic modalities such as UV-B on dithranol-induced dermatitis. The recognition of this adaptive mechanism may open future prospects to overcome some limitations concerning the practical use of dithranol.

Original languageEnglish
Pages (from-to)1-20
Number of pages20
JournalSkin Pharmacology and Physiology
Volume3
Issue number1
DOIs
Publication statusPublished - 1990

Fingerprint

Anthralin
Psoriasis
Dermatitis
Superoxides
Free Radicals
Pharmaceutical Preparations
Eicosanoids
Platelet Activating Factor
Immunosuppressive Agents
Keratinocytes
Granulocytes
Histamine
Reactive Oxygen Species
Staining and Labeling

Keywords

  • Adaptation process
  • Dithranol
  • Mode of action
  • Side-effects

ASJC Scopus subject areas

  • Physiology
  • Dermatology
  • Pharmacology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Dithranol : A review of the mechanism of action in the treatment of psoriasis vulgaris. / Kemény, L.; Ruzicka, Thomas; Braun-Falco, Otto.

In: Skin Pharmacology and Physiology, Vol. 3, No. 1, 1990, p. 1-20.

Research output: Contribution to journalArticle

@article{16298f08eb13453ba2434d0b2dc3f878,
title = "Dithranol: A review of the mechanism of action in the treatment of psoriasis vulgaris",
abstract = "Dithranol is highly effective in the treatment of psoriasis. The drug inhibits keratinocyte hyperproliferation, granulocyte function and, in addition, may exert an immunosuppressive effect. Free radicals, histamine, eicosanoids and platelet-activating factor have been shown to be involved in dithranol-induced dermatitis, and the oxidation products of the drug are responsible for the staining. Our experimental data suggest that extracellularly generated oxygen free radicals are responsible for both the antipsoriatic and irritative effect of the drug. Furthermore, we could recently provide evidence that extracellularly generated superoxide anion radical also induces an active adaptation mechanism resulting in increased tolerance to dithranol upon repeated application. This adaptive process may explain the requirement for increasing dithranol concentrations to maintain the antipsoriatic efficacy, and also the beneficial effect of other antipsoriatic modalities such as UV-B on dithranol-induced dermatitis. The recognition of this adaptive mechanism may open future prospects to overcome some limitations concerning the practical use of dithranol.",
keywords = "Adaptation process, Dithranol, Mode of action, Side-effects",
author = "L. Kem{\'e}ny and Thomas Ruzicka and Otto Braun-Falco",
year = "1990",
doi = "10.1159/000210836",
language = "English",
volume = "3",
pages = "1--20",
journal = "Skin Pharmacology and Physiology",
issn = "1660-5527",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Dithranol

T2 - A review of the mechanism of action in the treatment of psoriasis vulgaris

AU - Kemény, L.

AU - Ruzicka, Thomas

AU - Braun-Falco, Otto

PY - 1990

Y1 - 1990

N2 - Dithranol is highly effective in the treatment of psoriasis. The drug inhibits keratinocyte hyperproliferation, granulocyte function and, in addition, may exert an immunosuppressive effect. Free radicals, histamine, eicosanoids and platelet-activating factor have been shown to be involved in dithranol-induced dermatitis, and the oxidation products of the drug are responsible for the staining. Our experimental data suggest that extracellularly generated oxygen free radicals are responsible for both the antipsoriatic and irritative effect of the drug. Furthermore, we could recently provide evidence that extracellularly generated superoxide anion radical also induces an active adaptation mechanism resulting in increased tolerance to dithranol upon repeated application. This adaptive process may explain the requirement for increasing dithranol concentrations to maintain the antipsoriatic efficacy, and also the beneficial effect of other antipsoriatic modalities such as UV-B on dithranol-induced dermatitis. The recognition of this adaptive mechanism may open future prospects to overcome some limitations concerning the practical use of dithranol.

AB - Dithranol is highly effective in the treatment of psoriasis. The drug inhibits keratinocyte hyperproliferation, granulocyte function and, in addition, may exert an immunosuppressive effect. Free radicals, histamine, eicosanoids and platelet-activating factor have been shown to be involved in dithranol-induced dermatitis, and the oxidation products of the drug are responsible for the staining. Our experimental data suggest that extracellularly generated oxygen free radicals are responsible for both the antipsoriatic and irritative effect of the drug. Furthermore, we could recently provide evidence that extracellularly generated superoxide anion radical also induces an active adaptation mechanism resulting in increased tolerance to dithranol upon repeated application. This adaptive process may explain the requirement for increasing dithranol concentrations to maintain the antipsoriatic efficacy, and also the beneficial effect of other antipsoriatic modalities such as UV-B on dithranol-induced dermatitis. The recognition of this adaptive mechanism may open future prospects to overcome some limitations concerning the practical use of dithranol.

KW - Adaptation process

KW - Dithranol

KW - Mode of action

KW - Side-effects

UR - http://www.scopus.com/inward/record.url?scp=0025334870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025334870&partnerID=8YFLogxK

U2 - 10.1159/000210836

DO - 10.1159/000210836

M3 - Article

C2 - 2202336

AN - SCOPUS:0025334870

VL - 3

SP - 1

EP - 20

JO - Skin Pharmacology and Physiology

JF - Skin Pharmacology and Physiology

SN - 1660-5527

IS - 1

ER -